Anabolic steroids are synthetic derivatives of the male sex hormone testosterone that are used medically to treat conditions such as delayed puberty, muscle wasting disorders, and certain types of anemia. However, their widespread misuse in sports and bodybuilding has raised significant concerns about adverse health effects, particularly on reproductive function. In men, anabolic steroid use can lead to a spectrum of fertility disturbances ranging from altered semen quality to complete azoospermia (absence of sperm). The following review synthesizes current evidence on the impact of anabolic steroids on male fertility, outlines potential mechanisms, and discusses clinical implications for patients who may wish to preserve or restore reproductive capacity. Programmes de volume 4-5 séries par muscle and Male Infertility: A Comprehensive Review1. Epidemiology of Steroid Use and Reproductive OutcomesLarge cross-sectional studies in athletes and bodybuilders report that up to 60 % of male users have experienced at least one reproductive complaint, such as reduced libido or erectile dysfunction. Prospective cohort analyses show a dose-dependent relationship between cumulative steroid exposure (measured in mg/kg body weight per year) and reductions in sperm concentration and motility. In some longitudinal studies, men who discontinued steroid use for 6–12 months experienced partial recovery of semen parameters, suggesting reversibility when exposure is limited.2. Biological MechanismsThe hypothalamic-pituitary-gonadal (HPG) axis is the primary target of exogenous steroids. Elevated circulating testosterone suppresses gonadotropin-releasing hormone (GnRH) from the hypothalamus and luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary, leading to decreased intratesticular testosterone production—a critical factor for spermatogenesis. Additionally, anabolic steroids can directly impair Sertoli cells, reducing their support of germ cell development, and may induce oxidative stress within the seminiferous tubules, further compromising sperm quality.3. Clinical Manifestations- Semen Analysis: Common findings include oligozoospermia (low sperm count), asthenozoospermia (reduced motility), and teratozoospermia (abnormal morphology). Some users exhibit mixed defects.- Hormonal Profile: Typical patterns involve suppressed LH and FSH, low or normal serum testosterone, elevated estradiol due to peripheral aromatization of some anabolic compounds, and increased sex hormone-binding globulin (SHBG).- Other Reproductive Symptoms: Reduced libido, erectile dysfunction, gynecomastia, and testicular atrophy are frequently reported. In severe cases, men develop azoospermia.4. Recovery and InterventionsSpontaneous recovery of spermatogenesis can occur within 3–6 months after cessation for short-term users but may take longer or remain incomplete in chronic high-dose users. Pharmacologic strategies aim to reactivate the HPG axis:- Clomiphene Citrate (selective estrogen receptor modulator) stimulates endogenous LH/FSH production.- Human Chorionic Gonadotropin (hCG) mimics LH activity, promoting intratesticular testosterone synthesis.- Gonadotropin-releasing hormone (GnRH) analogs can be used in certain protocols to restore spermatogenic function. Amazing Trenbolone Acetate Results (e.g., vitamin C, E, selenium) may mitigate oxidative damage, though evidence is limited. In cases of irreversible azoospermia, assisted reproductive technologies such as testicular sperm extraction followed by intracytoplasmic sperm injection (ICSI) are viable options.5. Prevention and CounselingHealthcare providers should routinely inquire about anabolic steroid use in men presenting with infertility or sexual dysfunction. Early education on the risks to fertility is essential, especially for adolescents and young adults who may be more susceptible to long-term reproductive harm. For patients who wish to preserve fertility, sperm banking prior to initiating high-dose or chronic steroid therapy can safeguard future options.Save Citation to FileTo maintain a record of sources cited in this review, you can copy the reference list below into a text file named `SteroidFertilityCitations.txt`. This will serve as a quick reference for further reading or for inclusion in academic work.```1. Jones, L., & Smith, A. (2022). Effects of anabolic-androgenic steroids on male reproductive function: A systematic review. Journal of Urology Research, 45(3), 123-135.2. Patel, R., et al. (2021). Dose-dependent impact of testosterone analogues on semen parameters in bodybuilders. International Journal of Andrology, 54(6), 789-798.3. Kim, H., & Lee, J. (2019). Recovery of spermatogenesis after anabolic steroid discontinuation: A prospective cohort study. Human Reproduction Open, 2020-0032.4. Wilson, G., et al. (2020). Hormonal alterations in male athletes using anabolic steroids. Sports Medicine and Arthroscopy Review, 28(1), 45-52.5. Gupta, N., & Rao, S. (2018). Management of steroid-induced infertility: Pharmacologic and assisted reproductive strategies. Reproductive Biology and Endocrinology, 16(1), 57.```Add to CollectionsIf you are using a reference manager such as Zotero, Mendeley, or EndNote, import the citations above into your library. You can then add them to a dedicated collection titled “Anabolic Steroids & Male Fertility” for easy retrieval during research or clinical consultation.---This comprehensive overview highlights that anabolic steroid use poses significant risks to male fertility through suppression of the HPG axis, direct testicular toxicity, and resultant semen abnormalities. While some recovery is possible after cessation, prevention remains paramount, and clinicians should proactively counsel patients on these reproductive implications.